Drug intelligence / Profile preview

4-{5-[(Z)-(2-imino-4-oxo-1,3-thiazolidin-5-ylidene)methyl]furan-2-yl}benzoic acid

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is a synthetic small molecule belonging to the benzoic acids class. Its chemical formula is C15H10N2O4S and it has a molecular weight of approximately 314.32 g/mol. The structure features a thiazolidinone moiety linked via a furan ring to a benzoic acid group. It is listed in DrugBank as an experimental compound (DB07539) and has not been approved for any medical use or clinical indication as of now. There are no known clinical trials or patents associated with this molecule, and its pharmacological action and mechanism of action remain uncharacterized[3].

Other names: DB07539DB-07539DB 07539

Targets

CDK2 (Cyclin-dependent kinase 2)

Beyond the preview

Go deeper on 4-{5-[(Z)-(2-imino-4-oxo-1,3-thiazolidin-5-ylidene)methyl]furan-2-yl}benzoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-{5-[(Z)-(2-imino-4-oxo-1,3-thiazolidin-5-ylidene)methyl]furan-2-yl}benzoic acid.

Explore the full profile